Cancer of the Lung in Progressive Systemic Sclerosis

Cancer of the lung in progressive systemic sclerosis.

An association between one of the collagen diseases, dermatomyositis, and malignant disease is well recognized; in a recent review Caldwell (1955) states that there are nearly 70 reported cases in which the association has been noted, and an incidence of 18 % malignancy in cases of dermatomyositis has been reported by Curtis, Blaylock, and Harrell (1952). Many authorities (Dowling, 1940; Freude...

Association between atherosclerosis and parenchymal lung involvement in systemic sclerosis

Background: Systemic sclerosis is an autoimmune disease affecting connective tissues, (including epidermal, subepidermal, microvasculature, etc.), leading to various extent of end-organ damage. The leading cause of mortality among these patients is lung involvement. The cardiovascular events happen more frequently in patients suffering systemic scleroderma, comparing to healthy population. This...

Progressive systemic sclerosis.

The pulmonary manifestations of progressive systemic sclerosis (PSS) are important determinants of a patient’s prognosis. Although the etiology and pathogenesis of PSS are unknown, it is recognized that this is a complex disease; it is likely that different genetic susceptibilities and environmental exposures lead to the disease in different individuals. Individuals with diffuse PSS tend to dev...

radiological findings in progressive systemic sclerosis (p.s.s.)

radiological findings of 20 patients with scleroderma have been described. we had cornmon and uncommon roentgen signs of scleroderma similar to other series and one case with mid esophagus narrowing which we think have not been reported previously.

Is systemic sclerosis interstitial lung disease slowly progressive?